Heartflow (NASDAQ:HTFL) Insider Sells 9,219 Shares

Key Points

• Heartflow insider Campbell Rogers sold 9,219 shares at an average price of $41.23, generating approximately $380,099. The transaction was conducted under a pre-arranged Rule 10b5-1 plan and reduced Rogers’ holdings by 9.64%.
• Heartflow shares recently traded at $45.53, near their 52-week high of $47.23. The company reported quarterly revenue of $64.08 million, up 47.7% year over year, and an adjusted loss of $0.07 per share that beat analyst expectations.
• Analysts maintain a generally positive view, with a consensus rating of “Moderate Buy” and an average price target of $43.43; JPMorgan and Piper Sandler recently raised their targets to $45.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the completion of the transaction, the insider owned 86,459 shares of the company's stock, valued at $3,564,704.57. This represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Heartflow Price Performance

Shares of NASDAQ:HTFL traded up $0.30 during trading on Wednesday, hitting $45.53. 2,938,828 shares of the company were exchanged, compared to its average volume of 1,751,769. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $47.23. The stock has a 50 day moving average of $30.00 and a 200 day moving average of $28.05. The company has a market cap of $3.96 billion and a PE ratio of -24.88.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company had revenue of $64.08 million during the quarter. The company's revenue was up 47.7% compared to the same quarter last year. Sell-side analysts forecast that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on HTFL. JPMorgan Chase & Co. upped their price target on Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a research report on Friday, August 14th. Piper Sandler restated an "overweight" rating and issued a $45.00 price objective (up from $38.00) on shares of Heartflow in a research report on Friday, August 14th. William Blair assumed coverage on shares of Heartflow in a research note on Monday, May 4th. They set an "outperform" rating for the company. Weiss Ratings raised shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 7th. Finally, Morgan Stanley increased their target price on shares of Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $43.43.

Hedge Funds Weigh In On Heartflow

A number of institutional investors have recently added to or reduced their stakes in HTFL. TrueMark Investments LLC increased its position in shares of Heartflow by 1.4% in the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company's stock worth $654,000 after purchasing an additional 379 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Heartflow in the fourth quarter valued at approximately $27,000. Strs Ohio lifted its position in Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company's stock valued at $112,000 after purchasing an additional 1,200 shares during the last quarter. Russell Investments Group Ltd. purchased a new position in Heartflow in the 4th quarter worth approximately $45,000. Finally, Legal & General Group Plc purchased a new position in Heartflow in the 3rd quarter worth approximately $59,000.

Heartflow Company Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source